Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors

Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4 Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents The discovery of colchicine-SAHA hybrids as a new class of antitumor agents Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors Design, Synthesis, and Pharmacological Evaluation of NovelN-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors Dual targeted 2-Benzylideneindanone pendant hydroxamic acid group exhibits selective HDAC6 inhibition along with tubulin stabilization effect